IGF1 and neoplasm: Using the 4‐tiered scale, the patients with no biochemical response (<20% reduction of IGF1) showed significantly lower H‐score of SSTR2A (P = .02, Kruskal‐Wallis) and larger tumour diameter (P = .025, one‐way ANOVA).